WF-536 Hydrochloride is a novel inhibitor of ROCK, inhibiting tumour metastasis in some animal models.
Uses
WF-536 is an orally active inhibitor of Rho-associated coiled-coil-containing protein kinase (ROCK). WF-536 has tumor anti-metastatic activity. WF-536 can be used for the research of cancer[1].
in vivo
WF-536 (oral; 0.3-3 mg/kg/day; for 28 days) inhibits Lewis lung carcinoma (LLC) metastasis and LLC-induced angiogenesis in mice[1].
Animal Model:
C57BL/6 mice (male, 6-week old)[1]
Dosage:
0.3, 1, 3 mg/kg
Administration:
Oral; daily; for 28 days
Result:
Significantly reduced the number of pulmonary metastatic colonies of LLC in a dose-dependent manner (0.3- 3 mg/kg).
References
[1] Nakajima, Masahide et al. Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions. European journal of pharmacology vol. 459,2-3 (2003): 113-20. DOI:10.1016/s0014-2999(02)02869-8